Lipocine
LPCN
LPCN
54 hedge funds and large institutions have $26.2M invested in Lipocine in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 53 → 54 (+1)
72% less capital invested
Capital invested by funds: $94.3M → $26.2M (-$68.1M)
Holders
54
Holding in Top 10
2
Calls
$1.76M
Puts
$1.46M
Top Buyers
| 1 | +$1.22M | |
| 2 | +$1.21M | |
| 3 | +$727K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$569K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$486K |
Top Sellers
| 1 | -$9.18M | |
| 2 | -$3.75M | |
| 3 | -$2.44M | |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$1.21M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$972K |